Q&A: Sublingual immunotherapy targets house dust mite allergy in adolescents
Adolescents aged 12 to 17 years with allergic rhinitis induced by house dust mites now can take a sublingual immunotherapy tablet approved by the FDA after review of multiple trials in this age group. The safety profiles for the house dust mite allergen extract tablet (Odactra, ALK) between adolescents and adults were comparable, with local application site reactions comprising most
Source: healio.com